Gilder, Gagnon, Howe & Co »

Amylyx Pharmaceuticals shares owned by Gilder, Gagnon, Howe & Co

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Gilder, Gagnon, Howe & Co from 13F filings

Historical chart of Gilder, Gagnon, Howe & Co investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Gilder, Gagnon, Howe & Co

Quarter filed Position value Share count Share price at filing
2023-09-30 $13M 688k 18.31

More positions owned by Gilder, Gagnon, Howe & Co

Netflix (NFLX)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Cloudflare Cl A Com (NET)
Shopify Cl A Sub Vtg Shs (SHOP)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Roblox Corp Cl A (RBLX)
Intuitive Surgical Com New (ISRG)
Duolingo Cl A Com (DUOL)
Toast Cl A (TOST)
Quanta Services (PWR)
Natera (NTRA)
Alnylam Pharmaceuticals (ALNY)
Tko Group Holdings Cl A (TKO)

View all positions for Gilder, Gagnon, Howe & Co

Top funds holding Amylyx Pharmaceuticals

FMR
Perceptive Advisors
BlackRock
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Saturn V Capital Management
Commodore Capital
First Light Asset Management
Point72 Asset Management
Henderson Group
Driehaus Capital Management
Almitas Capital
Goldman Sachs Group
Paradigm Biocapital Advisors

View all funds holding Amylyx Pharmaceuticals